" /> B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 - CISMeF





Preferred Label : B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1;

NCIt synonyms : B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1; B Lymphoblastic Leukemia Lymphoma with t 9 22 q34 q11 2 BCR-ABL 1; B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR::ABL1; B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion; B Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion;

NCIt definition : A precursor lymphoid neoplasm which is composed of B lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.;

Neoplastic status : Malignant;

ICD-O code : 9812/3;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.